SCHEMBL16360367

SCHEMBL16360367

CCc1ccc(S(=O)(=O)C(C)C)c(OC)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TP53 P04637 1/20 0.47
▸ PTGS2 P35354 1/20 0.42
▸ ALPL P05186 1/20 0.40
▸ SMN1; SMN2 Q16637 3/20 0.40
▸ TUBB1 Q9H4B7 1/20 0.40
▸ TRPV4 Q9HBA0 1/20 0.39
▸ HTT P42858 2/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ FOS P01100 1/20 0.38
▸ TTR P02766 1/20 0.38
▸ JUN P05412 1/20 0.38
▸ NR3C1 P04150 1/20 0.38
▸ HSD17B1 P14061 1/20 0.38
▸ HSD17B2 P37059 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 2/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ MAPT P10636 1/20 0.38
▸ MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25046085 0.80 TRPV4 (0.62) TP53PTGS2ALPLSMN1; SMN2TUBB1
SCHEMBL19938065 0.80 PKM (0.50) TP53PTGS2ALPLSMN1; SMN2TUBB1
SCHEMBL16308959 0.80 TP53 (0.49) TP53PTGS2ALPLSMN1; SMN2TUBB1
SCHEMBL30184732 0.80 TRPV4 (0.62) TP53PTGS2ALPLSMN1; SMN2TUBB1
SCHEMBL12180447 0.78 MCOLN3 (0.53) ALPLSMN1; SMN2TRPV4HTTCA2
SCHEMBL21276078 0.78 L3MBTL1 (0.41) TP53PTGS2SMN1; SMN2CA2ALDH1A1
SCHEMBL10886489 0.77 TP53 (0.47) TP53PTGS2ALPLSMN1; SMN2TUBB1
SCHEMBL20364526 0.77 GAA (0.49) TRPV4HTTCA2ALDH1A1LMNA
SCHEMBL13588814 0.72 HTR6 (0.56) CA2ALDH1A1MAPTMAPK1L3MBTL1
SCHEMBL10962659 0.71 SMN1; SMN2 (0.61) TP53ALPLSMN1; SMN2TUBB1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2595989-B1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMA (US) 2016-07-13 — — EP disclosed
WO-2011140425-A1 HETEROCYCLIC CHROMENE-SPIROCYCLIC PIPERIDINE AMIDES AS MODULATORS OF ION CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-11-10 — — WO disclosed
Send feedback